ANTINEOVASCULARISATION AGENTS
- aflibercept (PAVBLU, EYLEA HD, EYLEA, EYDENZELT, YESAFILI, ENZEEVU, AFLIVU)
- brolucizumab (BEOVU)
- faricimab (VABYSMO)
- ranibizumab (RANOPTO, LUCENTIS, MELVIZO)
- verteporfin (VISUDYNE)
Using Health Canada Drug Database
updated on 04Jun2026.